TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD.

Revenue Quarterly

0 2.5B 5B 7.5B Q1 '08: 2.6B Q2 '08: 2.8B Q3 '08: 2.8B Q4 '08: 2.8B Q1 '09: 3.1B Q2 '09: 3.4B Q3 '09: 3.5B Q4 '09: 6B Q1 '10: 3.7B Q2 '10: 3.8B Q3 '10: 4.2B Q4 '10: 4.4B Q1 '11: 4.1B Q2 '11: 4.2B Q3 '11: 4.3B Q4 '11: 5.7B Q1 '12: 5B Q2 '12: 5B Q3 '12: 5B Q4 '12: 5.2B Q1 '13: 4.9B Q2 '13: 4.9B Q3 '13: 5.1B Q4 '13: 5.4B Q1 '14: 5B Q2 '14: 5B Q3 '14: 5.1B Q4 '14: 5.2B Q1 '15: 5B Q2 '15: 5B Q3 '15: 4.8B Q4 '15: 4.9B Q1 '16: 4.8B Q1 '16: 4.8B Q2 '16: 5B Q3 '16: 5.6B Q4 '16: 6.5B Q1 '17: 5.7B Q2 '17: 5.7B Q3 '17: 5.6B Q4 '17: 5.4B Q1 '18: 5.1B Q2 '18: 4.7B Q3 '18: 4.5B Q4 '18: 4.4B Q1 '19: 4.1B Q2 '19: 4.2B Q3 '19: 4.1B Q4 '19: 4.5B Q1 '20: 4.4B Q2 '20: 3.9B Q3 '20: 4B Q4 '20: 4.5B Q1 '21: 4B Q2 '21: 3.9B Q3 '21: 3.9B Q4 '21: 4.1B Q1 '22: 3.7B Q2 '22: 3.8B Q3 '22: 3.6B Q4 '22: 3.9B Q1 '23: 3.7B Q2 '23: 3.9B Q3 '23: 3.9B Q4 '23: 4.5B Q1 '24: 3.8B Q2 '24: 4.2B Q3 '24: 4.3B Q4 '24: 4.2B Q1 '25: 3.9B Q2 '25: 4.2B Q3 '25: 4.5B Q4 '25: 4.7B Q1 '26: 4B Q2 '26: 4.1B Q1 '09 Q3 '11 Q1 '14 Q2 '16 Q4 '18 Q2 '21 Q4 '23 Q2 '26

Gross Profit Quarterly

0 1.5B 3B 4.5B Q1 '08: 1.4B Q2 '08: 1.5B Q3 '08: 1.5B Q4 '08: 1.6B Q1 '09: 1.6B Q2 '09: 1.8B Q3 '09: 1.9B Q4 '09: 2.1B Q1 '10: 2B Q2 '10: 2.1B Q3 '10: 2.5B Q4 '10: 2.5B Q1 '11: 2.2B Q2 '11: 2.2B Q3 '11: 2.2B Q4 '11: 2.9B Q1 '12: 2.6B Q2 '12: 2.7B Q3 '12: 2.6B Q4 '12: 2.8B Q1 '13: 2.6B Q2 '13: 2.6B Q3 '13: 2.6B Q4 '13: 2.9B Q1 '14: 2.7B Q2 '14: 2.7B Q3 '14: 2.8B Q4 '14: 2.9B Q1 '15: 2.8B Q2 '15: 2.9B Q3 '15: 2.8B Q4 '15: 2.8B Q1 '16: 2.8B Q1 '16: 2.6B Q2 '16: 2.9B Q3 '16: 2.8B Q4 '16: 3.4B Q1 '17: 2.8B Q2 '17: 2.9B Q3 '17: 2.6B Q4 '17: 2.4B Q1 '18: 2.3B Q2 '18: 2B Q3 '18: 2B Q4 '18: 2B Q1 '19: 1.9B Q2 '19: 1.9B Q3 '19: 1.8B Q4 '19: 2B Q1 '20: 2.1B Q2 '20: 1.8B Q3 '20: 1.9B Q4 '20: 2B Q1 '21: 1.9B Q2 '21: 1.9B Q3 '21: 1.8B Q4 '21: 2B Q1 '22: 1.7B Q2 '22: 1.8B Q3 '22: 1.7B Q4 '22: 1.8B Q1 '23: 1.6B Q2 '23: 1.8B Q3 '23: 1.9B Q4 '23: 2.4B Q1 '24: 1.8B Q2 '24: 2B Q3 '24: 2.1B Q4 '24: 2.1B Q1 '25: 1.9B Q2 '25: 2.1B Q3 '25: 2.3B Q4 '25: 2.7B Q1 '26: 2B Q2 '26: 2.2B Q1 '09 Q3 '11 Q1 '14 Q2 '16 Q4 '18 Q2 '21 Q4 '23 Q2 '26

Operating Income Quarterly

-15B -10B -5B 0 5B 10B 15B Q1 '08: 297M Q2 '08: 638M Q3 '08: 622M Q1 '09: 538M Q2 '09: 702M Q3 '09: 753M Q4 '09: 412M Q1 '10: 834M Q2 '10: 1.1B Q3 '10: 1.2B Q4 '10: 774M Q1 '11: 867M Q2 '11: 597M Q3 '11: 1B Q4 '11: 610M Q1 '12: 928M Q2 '12: 1B Q3 '12: -60M Q4 '12: 330M Q1 '13: 874M Q2 '13: -586M Q3 '13: 801M Q4 '13: 560M Q1 '14: 972M Q2 '14: 925M Q3 '14: 1.1B Q4 '14: 942M Q1 '15: 749M Q2 '15: 662M Q3 '15: 1B Q4 '15: 931M Q1 '16: 1.2B Q2 '16: 361M Q3 '16: 765M Q1 '17: 895M Q2 '17: -5.7B Q3 '17: 378M Q4 '17: -13B Q1 '18: 1.5B Q2 '18: -14M Q3 '18: 16M Q4 '18: -3.2B Q1 '19: 134M Q2 '19: -644M Q3 '19: -81M Q4 '19: 148M Q1 '20: 191M Q2 '20: 173M Q3 '20: -4.3B Q4 '20: 406M Q1 '21: 434M Q2 '21: 582M Q3 '21: 623M Q4 '21: 78M Q1 '22: -713M Q2 '22: -949M Q3 '22: 419M Q4 '22: -940M Q1 '23: -13M Q2 '23: -654M Q3 '23: 344M Q4 '23: 756M Q1 '24: -218M Q2 '24: -5M Q3 '24: -51M Q4 '24: -29M Q1 '25: 519M Q2 '25: 455M Q3 '25: 882M Q4 '25: 300M Q1 '26: 652M Q2 '26: -231M Q2 '10 Q3 '12 Q4 '14 Q2 '17 Q3 '19 Q4 '21 Q1 '24 Q2 '26

Net Income Quarterly

-12B -8B -4B 0 4B 8B 12B Q1 '08: 139M Q2 '08: 533M Q3 '08: 631M Q1 '09: 451M Q2 '09: 521M Q3 '09: 649M Q4 '09: 379M Q1 '10: 713M Q2 '10: 797M Q3 '10: 1.1B Q4 '10: 771M Q1 '11: 761M Q2 '11: 576M Q3 '11: 916M Q4 '11: 506M Q1 '12: 859M Q2 '12: 863M Q3 '12: -79M Q4 '12: 320M Q1 '13: 630M Q2 '13: -452M Q3 '13: 711M Q4 '13: 380M Q1 '14: 744M Q2 '14: 748M Q3 '14: 876M Q4 '14: 687M Q1 '15: 446M Q2 '15: 539M Q3 '15: 103M Q4 '15: 500M Q1 '16: 636M Q2 '16: 254M Q3 '16: 412M Q1 '17: 645M Q2 '17: -6B Q3 '17: 595M Q4 '17: -11.5B Q1 '18: 1.1B Q2 '18: -176M Q3 '18: -208M Q4 '18: -2.9B Q1 '19: -105M Q2 '19: -689M Q3 '19: -314M Q4 '19: 110M Q1 '20: 69M Q2 '20: 140M Q3 '20: -4.3B Q4 '20: 150M Q1 '21: 77M Q2 '21: 207M Q3 '21: 292M Q1 '22: -955M Q2 '22: -232M Q3 '22: 56M Q4 '22: -1.3B Q1 '23: -220M Q2 '23: -872M Q3 '23: 69M Q4 '23: 464M Q1 '24: -139M Q2 '24: -846M Q3 '24: -437M Q4 '24: -217M Q1 '25: 214M Q2 '25: 282M Q3 '25: 433M Q4 '25: 480M Q1 '26: 369M Q2 '26: -576M Q1 '10 Q2 '12 Q3 '14 Q1 '17 Q2 '19 Q3 '21 Q1 '24 Q2 '26

Cost of Revenue Quarterly

0 1.5B 3B 4.5B Q1 '08: 1.2B Q2 '08: 1.3B Q3 '08: 1.4B Q4 '08: 1.2B Q1 '09: 1.6B Q2 '09: 1.6B Q3 '09: 1.6B Q4 '09: 1.7B Q1 '10: 1.6B Q2 '10: 1.7B Q3 '10: 1.8B Q4 '10: 2B Q1 '11: 1.9B Q2 '11: 2B Q3 '11: 2.1B Q4 '11: 2.8B Q1 '12: 2.5B Q2 '12: 2.3B Q3 '12: 2.4B Q4 '12: 2.5B Q1 '13: 2.3B Q2 '13: 2.3B Q3 '13: 2.4B Q4 '13: 2.5B Q1 '14: 2.3B Q2 '14: 2.4B Q3 '14: 2.2B Q4 '14: 2.3B Q1 '15: 2.1B Q2 '15: 2.1B Q3 '15: 2.1B Q4 '15: 2B Q1 '16: 2B Q1 '16: 2.2B Q2 '16: 2.2B Q3 '16: 2.8B Q4 '16: 3.1B Q1 '17: 2.8B Q2 '17: 2.9B Q3 '17: 3B Q4 '17: 2.6B Q1 '18: 2.8B Q2 '18: 2.7B Q3 '18: 2.6B Q4 '18: 2B Q1 '19: 2.3B Q2 '19: 2.3B Q3 '19: 2.3B Q4 '19: 2.5B Q1 '20: 2.3B Q2 '20: 2.1B Q3 '20: 2.1B Q4 '20: 2.4B Q1 '21: 2.1B Q2 '21: 2B Q3 '21: 2.1B Q4 '21: 2B Q1 '22: 1.9B Q2 '22: 2B Q3 '22: 1.9B Q4 '22: 2.1B Q1 '23: 2.1B Q2 '23: 2.1B Q3 '23: 2B Q4 '23: 2B Q1 '24: 2B Q2 '24: 2.1B Q3 '24: 2.2B Q4 '24: 2.1B Q1 '25: 2B Q2 '25: 2.1B Q3 '25: 2.2B Q4 '25: 2.1B Q1 '26: 2B Q2 '26: 2B Q1 '09 Q3 '11 Q1 '14 Q2 '16 Q4 '18 Q2 '21 Q4 '23 Q2 '26

Operating Cash Flow Quarterly

-600M 0 600M 1.2B 1.8B Q1 '08: 746M Q2 '08: 806M Q3 '08: 710M Q4 '08: 969M Q1 '09: 733M Q2 '09: 658M Q3 '09: 1B Q4 '09: 957M Q1 '10: 886M Q2 '10: 954M Q3 '10: 1.2B Q4 '10: 1.1B Q1 '11: 900M Q2 '11: 1.3B Q3 '11: 482M Q4 '11: 1.4B Q1 '12: 756M Q2 '12: 1.2B Q3 '12: 1B Q4 '12: 1.6B Q1 '13: 1.1B Q2 '13: 875M Q3 '13: 444M Q4 '13: 816M Q1 '14: 898M Q2 '14: 1.1B Q3 '14: 1.4B Q4 '14: 1.8B Q1 '15: 1.4B Q2 '15: 1.5B Q3 '15: 1.1B Q4 '15: 1.6B Q1 '16: 1.4B Q1 '16: 41M Q2 '16: 963M Q3 '16: 1.5B Q4 '16: 1.4B Q1 '17: 136M Q2 '17: 435M Q3 '17: 795M Q4 '17: 859M Q1 '18: 1.5B Q2 '18: 162M Q3 '18: 421M Q4 '18: 367M Q1 '19: 112M Q2 '19: -227M Q3 '19: 325M Q4 '19: 538M Q1 '20: 305M Q2 '20: 273M Q3 '20: 307M Q4 '20: 331M Q1 '21: -405M Q2 '21: 218M Q3 '21: 529M Q4 '21: 456M Q1 '22: -49M Q2 '22: 123M Q3 '22: 543M Q4 '22: 973M Q1 '23: -145M Q2 '23: 324M Q3 '23: 5M Q4 '23: 1.2B Q1 '24: -124M Q2 '24: 103M Q3 '24: 693M Q4 '24: 575M Q1 '25: -105M Q2 '25: 227M Q3 '25: 369M Q4 '25: 1.2B Q1 '26: -40M Q2 '26: 411M Q1 '09 Q3 '11 Q1 '14 Q2 '16 Q4 '18 Q2 '21 Q4 '23 Q2 '26

Free Cash Flow Quarterly

-1B -500M 0 500M 1B 1.5B Q1 '08: 604M Q2 '08: 626M Q3 '08: 532M Q4 '08: 788M Q1 '09: 573M Q2 '09: 507M Q3 '09: 829M Q4 '09: 745M Q1 '10: 721M Q2 '10: 818M Q3 '10: 1B Q4 '10: 868M Q1 '11: 666M Q2 '11: 1.1B Q3 '11: 206M Q4 '11: 1.1B Q1 '12: 482M Q2 '12: 937M Q3 '12: 799M Q4 '12: 1.2B Q1 '13: 838M Q2 '13: 650M Q3 '13: 216M Q4 '13: 502M Q1 '14: 673M Q2 '14: 861M Q3 '14: 1.2B Q4 '14: 1.5B Q1 '15: 1.2B Q2 '15: 1.3B Q3 '15: 923M Q4 '15: 1.4B Q1 '16: 1.2B Q1 '16: -131M Q2 '16: 788M Q3 '16: 1.2B Q4 '16: 1.1B Q1 '17: -66M Q2 '17: 242M Q3 '17: 583M Q4 '17: 592M Q1 '18: 1.3B Q2 '18: 26M Q3 '18: 282M Q4 '18: 154M Q1 '19: -13M Q2 '19: -339M Q3 '19: 156M Q4 '19: 419M Q1 '20: 177M Q2 '20: 142M Q3 '20: 164M Q4 '20: 155M Q1 '21: -555M Q2 '21: 105M Q3 '21: 383M Q4 '21: 303M Q1 '22: -206M Q2 '22: -4M Q3 '22: 421M Q4 '22: 831M Q1 '23: -284M Q2 '23: 205M Q3 '23: -144M Q4 '23: 1.1B Q1 '24: -248M Q2 '24: 6M Q3 '24: 545M Q4 '24: 446M Q1 '25: -232M Q2 '25: 131M Q3 '25: 233M Q4 '25: 1B Q1 '26: -208M Q2 '26: 307M Q1 '09 Q3 '11 Q1 '14 Q2 '16 Q4 '18 Q2 '21 Q4 '23 Q2 '26

Operating cash flow minus capital expenditure.

Shares Outstanding Quarterly

0 500M 1B 1.5B Q1 '08: 817M Q2 '08: 836M Q3 '08: 837M Q1 '09: 894M Q2 '09: 895M Q3 '09: 915M Q1 '10: 921M Q2 '10: 921M Q3 '10: 921M Q1 '11: 902M Q2 '11: 896M Q3 '11: 890M Q1 '12: 882M Q2 '12: 873M Q3 '12: 869M Q1 '13: 856M Q2 '13: 849M Q3 '13: 846M Q1 '14: 852M Q2 '14: 857M Q3 '14: 861M Q1 '15: 859M Q2 '15: 859M Q3 '15: 862M Q1 '16: 920M Q2 '16: 920M Q3 '16: 984M Q1 '17: 1B Q2 '17: 1B Q3 '17: 1B Q1 '18: 1B Q2 '18: 1B Q3 '18: 1B Q1 '19: 1.1B Q2 '19: 1.1B Q3 '19: 1.1B Q1 '20: 1.1B Q2 '20: 1.1B Q3 '20: 1.1B Q1 '21: 1.1B Q2 '21: 1.1B Q3 '21: 1.1B Q1 '22: 1.1B Q2 '22: 1.1B Q3 '22: 1.1B Q1 '23: 1.1B Q2 '23: 1.1B Q3 '23: 1.1B Q1 '24: 1.1B Q2 '24: 1.1B Q3 '24: 1.1B Q1 '25: 1.2B Q2 '25: 1.2B Q3 '25: 1.2B Q1 '26: 1.2B Q2 '26: 1.2B Q1 '10 Q2 '12 Q3 '14 Q1 '17 Q2 '19 Q3 '21 Q1 '24 Q2 '26

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

-18.00 -12.00 -6.00 0.00 6.00 12.00 18.00 Q4 '09: 2.23 Q1 '10: 2.51 Q2 '10: 2.81 Q3 '10: 3.24 Q4 '10: 3.67 Q1 '11: 3.72 Q2 '11: 3.48 Q3 '11: 3.36 Q4 '11: 3.09 Q1 '12: 3.22 Q2 '12: 3.57 Q3 '12: 2.45 Q4 '12: 2.24 Q1 '13: 2.01 Q2 '13: 0.49 Q3 '13: 1.42 Q4 '13: 1.50 Q1 '14: 1.63 Q2 '14: 3.03 Q3 '14: 3.21 Q4 '14: 3.56 Q1 '15: 3.21 Q2 '15: 2.97 Q3 '15: 2.07 Q4 '15: 1.83 Q1 '16: 1.93 Q4 '16: 0.07 Q1 '17: 0.10 Q2 '17: -6.04 Q3 '17: -5.87 Q4 '17: -16.26 Q1 '18: -15.80 Q2 '18: -10.10 Q3 '18: -10.89 Q4 '18: -2.33 Q1 '19: -3.46 Q2 '19: -3.85 Q3 '19: -3.87 Q4 '19: -0.92 Q1 '20: -0.76 Q2 '20: 0.00 Q3 '20: -3.68 Q4 '20: -3.64 Q1 '21: -3.63 Q2 '21: -3.57 Q3 '21: 0.66 Q4 '22: -2.19 Q1 '23: -1.53 Q2 '23: -2.10 Q3 '23: -2.09 Q4 '23: -0.50 Q1 '24: -0.42 Q2 '24: -0.39 Q3 '24: -0.84 Q4 '24: -1.45 Q1 '25: -1.15 Q2 '25: -0.16 Q3 '25: 0.60 Q4 '25: 1.20 Q1 '26: 1.33 Q2 '26: 0.60 Q4 '10 Q4 '12 Q4 '14 Q2 '17 Q2 '19 Q2 '21 Q2 '24 Q2 '26

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.